Stanford's Mark Pegram discusses breast cancer in the genomic age

In this video, Mark Pegram, MD, director of the breast oncology program at Stanford, explains how genomic applications have been applied recently to breast cancer in terms of new molecular diagnostics and how this practice has resulted in emerging treatment opportunities. During the talk, he also discusses the potential future of diagnostics and therapeutics based on a fundamental understanding of the molecular biology of breast cancer.